Rite Aid implements medication disposal program
CAMP HILL, Pa. — Rite Aid is working with Sharps Compliance to help customers dispose of unused medications, the retailer said Monday.
Customers can buy a Sharps Compliance medication-disposal envelope at a Rite Aid store for $3.99, place unused prescriptions or over-the-counter drugs inside and then send it via the U.S. Postal Service to the incinerator.
“For years, Rite Aid has participated in community medication take-back events organized by local health officials and law enforcement agencies,” Rite Aid SVP pharmacy Dan Miller said. “Our customers often ask how to dispose of medication. By making these envelopes available in our stores, we’re offering an easy and safe disposal solution for customers looking to safely dispose of expired, unused or unwanted medications.”
Rite Aid said the envelopes are available at all Rite Aid stores except for those in Maine, where another program is available. Last March, Sharps Compliance teamed up with the National Community Pharmacists Association to offer member pharmacies discounted services for the Sharps TakeAway Environmental Return System.
Gilead to shareholders: Say no to mini-tender offer by TRC
FOSTER CITY, Calif. — Drug maker Gilead acknowledged the receipt of an unsolicited mini-tender offer by TRC Capital.
Gilead said that TRC seeks to purchase up to 3 million shares of the company at a price of $37.25 per share, or about $111.75 million. The drug maker said it is recommending shareholders reject the bid, stating that the offer is priced below the current market price for Gilead shares and is subject to numerous conditions. As of March 2, TRC’s offer price represented approximately a 4.56% discount to the $39.03 closing price of Gilead common stock.
Mini-tender offers are designed to acquire less than 5% of a company’s outstanding shares, thereby avoiding many disclosure and procedural requirements of the Securities and Exchange Commission that apply to offers for more than 5% of a company’s outstanding shares.
GSK develops community pharmacy team
RESEARCH TRIANGLE PARK, N.C. — GlaxoSmithKline said it is establishing a dedicated team to support community pharmacists and other healthcare professionals.
Effective March 28, GSK said its community pharmacy liaisons will provide information and tools to help community pharmacists communicate with their patients about chronic diseases and the appropriate use of medicines and vaccines.
In developing the new team, the drug maker said it consulted with community pharmacists to better understand their needs and to ensure that the new team will provide a helpful service.
“Our research shows that community pharmacists want to spend more time engaging with their patients, and many patients would welcome more counseling about their medication,” said David Moules, GSK VP channel development and sales. “The GSK community pharmacy team will provide community pharmacists with education and tools to support those important patient conversations.”